Commonwealth Equity Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$113M Sell
319,923
-17,484
-5% -$6.23M 0.16% 125
2025
Q4
$110M Sell
337,407
-36,721
-10% -$11.6M 0.15% 133
2025
Q3
$106M Sell
374,128
-37,667
-9% -$10.9M 0.14% 142
2025
Q2
$115M Sell
411,795
-4,622
-1% -$1.31M 0.15% 123
2025
Q1
$130M Buy
416,417
+17,183
+4% +$5.07M 0.18% 107
2024
Q4
$104M Buy
399,234
+11,878
+3% +$3.52M 0.15% 125
2024
Q3
$125M Buy
387,356
+486
+0.1% +$159K 0.19% 98
2024
Q2
$121M Sell
386,870
-7,150
-2% -$2.1M 0.19% 96
2024
Q1
$112M Buy
394,020
+10,942
+3% +$3.2M 0.19% 102
2023
Q4
$110M Buy
383,078
+7,296
+2% +$1.99M 0.2% 98
2023
Q3
$101M Buy
375,782
+11,309
+3% +$2.82M 0.21% 93
2023
Q2
$80.9M Sell
364,473
-15,067
-4% -$3.5M 0.16% 123
2023
Q1
$91.8K Buy
379,540
+37,191
+11% +$9.13M 0.19% 107
2022
Q4
$89.9M Buy
342,349
+4,888
+1% +$1.31M 0.22% 95
2022
Q3
$76.1M Buy
337,461
+1,024
+0.3% +$248K 0.2% 97
2022
Q2
$81.9M Sell
336,437
-980
-0.3% -$240K 0.21% 91
2022
Q1
$81.6M Buy
337,417
+8,104
+2% +$1.86M 0.19% 107
2021
Q4
$74.1M Buy
329,313
+11,276
+4% +$2.38M 0.17% 124
2021
Q3
$67.6M Buy
318,037
+5,163
+2% +$1.19M 0.17% 127
2021
Q2
$76.3M Buy
312,874
+11,672
+4% +$2.87M 0.19% 105
2021
Q1
$74.9M Sell
301,202
-319
-0.1% -$76.1K 0.21% 91
2020
Q4
$69.3M Sell
301,521
-9,012
-3% -$2.08M 0.21% 96
2020
Q3
$78.9M Sell
310,533
-5,195
-2% -$1.29M 0.27% 77
2020
Q2
$74.5M Buy
315,728
+16,110
+5% +$3.68M 0.28% 75
2020
Q1
$60.7M Buy
299,618
+12,587
+4% +$2.75M 0.28% 75
2019
Q4
$69.2M Buy
287,031
+10,996
+4% +$2.42M 0.26% 75
2019
Q3
$53.4M Buy
276,035
+5,020
+2% +$964K 0.23% 87
2019
Q2
$49.9M Buy
271,015
+9,207
+4% +$1.65M 0.22% 92
2019
Q1
$49.7M Buy
261,808
+6,731
+3% +$1.29M 0.23% 87
2018
Q4
$49.7M Buy
255,077
+7,721
+3% +$1.51M 0.26% 78
2018
Q3
$51.3M Sell
247,356
-1,493
-0.6% -$294K 0.25% 84
2018
Q2
$45.9M Buy
248,849
+3,143
+1% +$556K 0.24% 90
2018
Q1
$41.9M Buy
245,706
+2,528
+1% +$464K 0.23% 100
2017
Q4
$42.3M Buy
243,178
+12,432
+5% +$2.2M 0.23% 96
2017
Q3
$43M Buy
230,746
+3,409
+1% +$604K 0.26% 90
2017
Q2
$39.2M Sell
227,337
-2,325
-1% -$378K 0.25% 89
2017
Q1
$37.7M Buy
229,662
+40,510
+21% +$6.73M 0.25% 87
2016
Q4
$27.7M Sell
189,152
-1,978
-1% -$298K 0.2% 102
2016
Q3
$31.9M Sell
191,130
-1,638
-0.8% -$277K 0.25% 80
2016
Q2
$29.3M Buy
192,768
+11,266
+6% +$1.75M 0.25% 83
2016
Q1
$27.2M Buy
181,502
+5,302
+3% +$788K 0.24% 87
2015
Q4
$28.6M Buy
176,200
+14,118
+9% +$2.22M 0.27% 76
2015
Q3
$22.4M Buy
162,082
+50,272
+45% +$7.92M 0.24% 91
2015
Q2
$17.2M Buy
111,810
+15,509
+16% +$2.48M 0.17% 128
2015
Q1
$15.4M Buy
96,301
+9,328
+11% +$1.47M 0.16% 137
2014
Q4
$13.9M Buy
86,973
+9,481
+12% +$1.48M 0.16% 133
2014
Q3
$10.9M Buy
77,492
+1,397
+2% +$182K 0.13% 148
2014
Q2
$9.01M Buy
76,095
+6,033
+9% +$698K 0.11% 177
2014
Q1
$8.64M Buy
70,062
+3,385
+5% +$411K 0.12% 168
2013
Q4
$7.61M Buy
66,677
+1,414
+2% +$161K 0.11% 180
2013
Q3
$7.3M Buy
65,263
+1,628
+3% +$177K 0.12% 169
2013
Q2
$6.28M Buy
+63,635
New +$6.6M 0.11% 174

Other funds holding AMGN

Commonwealth Equity Services's AMGN Position: Q1 2026 in Review

Commonwealth Equity Services reduced its Amgen (AMGN) stake by 5.2% in Q1 2026, selling an estimated $6.23M and leaving 319,923 shares worth $113M. The position accounts for 0.16% of the portfolio, ranked #125.

Commonwealth Equity Services first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $130M in Q1 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Commonwealth Equity Services held 319,923 shares of Amgen worth $113M as of Q1 2026.
  • Commonwealth Equity Services sold 17,484 Amgen shares in Q1 2026, an estimated $6.23M.
  • Amgen made up 0.16% of Commonwealth Equity Services's portfolio in Q1 2026, its #125 holding.
  • Commonwealth Equity Services first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Commonwealth Equity Services's Amgen position peaked at $130M in Q1 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.